Cullinan Oncology
CGEM
CGEM
81 hedge funds and large institutions have $386M invested in Cullinan Oncology in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
27% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 30
31% less capital invested
Capital invested by funds: $559M → $386M (-$173M)
Holders
81
Holding in Top 10
5
Calls
$1.37M
Puts
$490K
Top Buyers
| 1 | +$7.22M | |
| 2 | +$2.89M | |
| 3 | +$1.76M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.08M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$976K |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$1.58M | |
| 3 | -$1.41M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$982K |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$926K |